 TCTMD | TWENTE: Still Few Differences between ZES and EES at 2 Years TCTMD At 2-year follow-up, a zotorolimus-eluting stent (ZES) and an everolimus-eluting stent (EES) demonstrated similar safety and efficacy in a real-world patient population characterized by complex lesions and off-label indications for drug-eluting stents ... |
